Summit Partners Public Asset Management »

BioMarin Pharmaceutical shares owned by Summit Partners Public Asset Management

Quarter-by-quarter ownership of BioMarin Pharmaceutical (BMRN) shares owned by Summit Partners Public Asset Management from 13F filings

Historical chart of Summit Partners Public Asset Management investment in BioMarin Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including BioMarin Pharmaceutical held by Summit Partners Public Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioMarin Pharmaceutical by Summit Partners Public Asset Management

Quarter filed Position value Share count Share price at filing
2023-03-31 $23M 233k 97.24
2022-12-31 $20M 196k 103.49
2022-09-30 $8.4M 100k 84.14

More positions owned by Summit Partners Public Asset Management

Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Inspire Med Sys Put Option (INSP)
Mongodb Cl A (MDB)
Aptiv SHS (APTV)
MercadoLibre (MELI)
Rivian Automotive Com Cl A Put Option (RIVN)
Meta Platforms Cl A (META)
Super Micro Computer (SMCI)
Roku Com Cl A (ROKU)
Samsara Com Cl A Call Option (IOT)
Deckers Outdoor Corporation Put Option (DECK)
Airbnb Com Cl A Call Option (ABNB)
Palo Alto Networks (PANW)

View all positions for Summit Partners Public Asset Management

Top funds holding BioMarin Pharmaceutical

PRIMECAP Management Company
Vanguard Group
Dodge & Cox
Barclays
Viking Global Investors
venBio Select Advisor
Deutsche Bank Aktiengesellschaft
Norges Bank Investment Management
Elliott Investment Management
Henderson Group
Bank of New York Mellon
Jpmorgan Chase & Co
Bank of America Corporation
Nomura Holdings
Parnassus Investments

View all funds holding BioMarin Pharmaceutical